Estimated Glomerular Filtration Rate Changes in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

BACKGROUND: Chronic use of tyrosine kinase inhibitor (TKI) may lead to previously unrecognized adverse events. We evaluated the incidence of acute kidney injury (AKI) and chronic kidney disease (CKD) in chronic phase (CP) chronic myeloid leukemia (CML) patients treated with imatinib, dasatinib and n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Yilmaz, Musa, Lahoti, Amit, O'Brien, Susan, Nogueras-González, Graciela M., Burger, Jan, Ferrajoli, Alessandra, Borthakur, Gautam, Ravandi, Farhad, Pierce, Sherry, Jabbour, Elias, Kantarjian, Hagop, Cortes, Jorge E
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4519988/
https://ncbi.nlm.nih.gov/pubmed/26217876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29587
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados